-->
Sharechat Logo

A2, Synlait agree to extend infant formula supply deal

Tuesday 3rd July 2018

Text too small?

Dairy marketer A2 Milk and milk processor Synlait Milk have agreed to extend their infant formula supply deal and increase the volume of formula Synlait will supply as the two continue to focus on sales in the lucrative Chinese market.

A2 and Synlait first signed a supply agreement in 2012 to support the milk marketing firm's plans to launch infant formula sales into China, and inked a new deal in August 2016 providing for increased scale if market demand warranted it.

The companies' arrangements were for a minimum of five years from 2016, with a rolling three-year term from August this year, but have been extended by two years so will last until at least July 2023. Synlait will increase the volume of infant formula products it is A2's exclusive supplier for and increase its committed production capacity.

They have also agreed on pricing terms "that reflect the commitment on the part of both companies to an ongoing market-competitive pricing regime", each company's statement to the NZX said. However, the companies either need shareholder approval for the changes or a waiver from NZX from needing to get shareholder approval. 

A2 said the extension was consistent with the global strategic supply strategy it has been developing, while Synlait said the agreement reinforces the close working relationship between the two "as they work to develop A2 Platinum for the ANZ and China markets on an exclusive basis to a specified product volume."

"This step is about bringing Synlait and the A2 Milk Co closer together in anticipation of continued growth,” Synlait managing director John Penno said. "It also puts both companies in a great position to further leverage the Chinese Food and Drug Agency (CFDA) registration of A2’s infant formula products, which was achieved in September 2017."

A2's managing director Geoffrey Babidge said the deal "has been carefully developed to provide the company with security for nutritionals supply to our key markets consistent with our overall strategic objective of maintaining high-quality supply with ongoing cost-competitiveness."

A2's shares last traded at $11.43, up 42 percent this year, while Synlait's were last at $11.39, up 58 percent. 

(BusinessDesk)

  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

Not much joy in Fellet's Sky TV swansong
Ebos says underlying net profit boosted by animal care segment
KiwiRail operating earnings start to improve as Picton-Christchurch rail link reopens
Spark 1H profit dips 5.6% as Southern Cross withholds dividend
Power panel favours scrapping low-fixed charges, prompt payment discounts
February 20th Morning Report
FIRST CUT: Fletcher betters first-half guidance with 8% ebit drop
Meridian posts record 1H operating earnings, raises dividend
FIRST CUT: A2 more than doubles 1H net profit
NZD lifts as US-China return to negotiating table, US seeking stable yuan

IRG See IRG research reports